Regadenoson versus Dipyridamole: A Comparison of the Frequency of Adverse Events in Patients Undergoing Myocardial Perfusion Imaging.

about

Regadenoson versus Dipyridamole: A Comparison of the Frequency of Adverse Events in Patients Undergoing Myocardial Perfusion Imaging.

Item

http://www.wikidata.org/entity/Q38802421

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Regadenoson versus Dipyridamol ...... Myocardial Perfusion Imaging.

@en

type

Item

label

Regadenoson versus Dipyridamol ...... Myocardial Perfusion Imaging.

@en

prefLabel

Regadenoson versus Dipyridamol ...... Myocardial Perfusion Imaging.

@en

P1476

Regadenoson versus Dipyridamol ...... Myocardial Perfusion Imaging.

@en

P2093

Gerald Cohen

http://www.w3.org/2001/XMLSchema#string

Jeff R Hurren

http://www.w3.org/2001/XMLSchema#string

Kallie A Amer

http://www.w3.org/2001/XMLSchema#string

Stephanie B Edwin

http://www.w3.org/2001/XMLSchema#string

P2860

Comparison and effectiveness of regadenoson versus dipyridamole on stress electrocardiographic changes during positron emission tomography evaluation of patients with hypertrophic cardiomyopathy.

Current advances in vasodilator pharmacological stress perfusion imaging.

Advances in pharmacologic stress agents: focus on regadenoson.

Radionuclide cardiac stress testing.

Myocardial perfusion imaging laboratory efficiency with the use of regadenoson compared to adenosine and dipyridamole.

Effects of age, gender, obesity, and diabetes on the efficacy and safety of the selective A2A agonist regadenoson versus adenosine in myocardial perfusion imaging integrated ADVANCE-MPI trial results.

Safety of regadenoson, an adenosine A2A receptor agonist for myocardial perfusion imaging, in mild asthma and moderate asthma patients: a randomized, double-blind, placebo-controlled trial.

Comparison of the myocardial blood flow response to regadenoson and dipyridamole: a quantitative analysis in patients referred for clinical 82Rb myocardial perfusion PET.

P304

657-661

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PHAR.1940

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-05-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28475259

http://www.w3.org/2001/XMLSchema#string